Daniel Kim, MD
Pain Medicine · Bloomington, ILNPI 1942286976
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 38.5% of the total. Reporting peaked in 2021 at $78 and has fallen 77.9% since, to $17 in 2025. That places this record below the midpoint for pain medicine clinicians in IL, where the typical reported total is $2,104.
Across 16 payments — averaging $15.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$97
- Merck$65
- Shionogi Inc$21
- Baudax Bio Inc.$20
- KARL Storz Endoscopy-america$13
- Johnson & Johnson$13
- plus $23 from 2 others
What the payments were for
- Food & beverage$251100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $97 |
| Merck | 4 | $65 |
| Shionogi Inc | 1 | $21 |
| Baudax Bio Inc. | 1 | $20 |
| KARL Storz Endoscopy-america | 1 | $13 |
| Johnson & Johnson | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Antares Pharma, Inc. | 1 | $11 |
How this compares
$251 in reported general payments places this provider in the 20th percentile of 233 pain medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Donepezil Hcl | 12 | $130 |
| Atorvastatin Calcium | 12 | $63 |
| Metoprolol Tartrate | 12 | $48 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Bloomington
- Ricardo VallejoBloomington$2.3M
- David DickersonEvanston$558K
- Thomas DahlbergRockford$218K
- Steven CohenChicago$217K
- Albert SinghQuincy$212K
- Nirav ShahSkokie$137K
- Ryan KutaNaperville$114K
- Anthony LebarioElgin$87K
- Keith SchmidtHoffman Estates$81K
- Jay HurhLibertyville$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.